N-ACETYLCYSTEINE AND/OR URSODEOXYCHOLIC ACID ASSOCIATED WITH METFORMIN IN NON-ALCOHOLIC STEATOHEPATITIS: AN OPEN-LABEL MULTICENTER RANDOMIZED CONTROLLED TRIAL.
Claudia Pinto Marques Souza de OliveiraHelma Pinchemel CotrimJose Tadeu StefanoAna Cristina G SiqueiraAna Lucia Azevedo SalgadoEdison Roberto ParisePublished in: Arquivos de gastroenterologia (2019)
This multicenter study suggests that the association of NAC + MTF could reduce the liver disease activity in patients with NASH. These data stimulate further controlled studies with this therapy for these patients.
Keyphrases
- disease activity
- randomized controlled trial
- rheumatoid arthritis
- systemic lupus erythematosus
- end stage renal disease
- rheumatoid arthritis patients
- ankylosing spondylitis
- newly diagnosed
- ejection fraction
- chronic kidney disease
- transcription factor
- study protocol
- prognostic factors
- juvenile idiopathic arthritis
- systematic review
- clinical trial
- cross sectional
- liver injury
- deep learning
- artificial intelligence
- data analysis
- meta analyses